← Back
Data updated: Mar 10, 2026
PPI-DAC
Pharmaceuticals
PPI-DAC is a generic drug manufacturer with 3 FDA-approved products.
2009
Since
3
Drugs
-
Trials
26
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NICOTINE POLACRILEX 2026-02-05
Labeling
NICOTINE POLACRILEX 2025-07-17
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-05-20
Labeling
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-05-20
Labeling
NICOTINE POLACRILEX 2025-04-01
Manufacturing (CMC)
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2024-09-10
NICOTINE POLACRILEX 2024-07-12
Manufacturing (CMC)
NICOTINE POLACRILEX 2024-04-30
Labeling
NICOTINE POLACRILEX 2024-03-27
Labeling
NICOTINE POLACRILEX 2024-03-27
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 2009-07-10
- Latest
- 2022-06-16
- Applications
- 4